👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Alvin Lee
Oncology
English
7,509+
Patients seen
2
Years in practice
11
Publications
1
Languages spoken
About
Dr Alvin Lee is a Consultant Medical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust where he also serves as skin cancer clinical research lead. He is also a Medical Lead at the Cancer Research UK (CRUK) Centre for Drug Development where he helps guide the development of new cancer therapies. He sees patients privately and specialises in melanoma.
He read preclinical medicine and natural sciences at the University of Cambridge. He completed his clinical training at University College London (UCL) as a graduate of the elite MB PhD programme. His doctoral research in drug resistance mechanisms in cancer won the UCL MB PhD Cordwainers’ Prize for best PhD thesis.
He completed his oncology training within the University College London rotations and gained translational research experience in Cambridge, Oxford and London including a clinical postdoctoral fellowship at the Francis Crick Institute.
In addition to GMC Specialist Registration in Medical Oncology, he has the European Society for Medical Oncology ESMO certification in Medical Oncology. He has postgraduate certifications (PG Cert) in Genomic Medicine from Imperial College London and his other postgraduate certifications are in Oncology, Clinical Research and Medical Education. As a Fellow of all three of the Royal Colleges of Physicians in the UK (FRCP London, Glasgow, Edinburgh), the Royal Society of Biology (FRSB), and the Royal Society of Arts (FRSA), he operates at the highest level of clinical and scientific recognition.
Dr Lee’s work focuses on the translation of discovery science into cancer treatments. He is dedicated to the advancement of precision oncology, utilising his extensive background in genomics and cancer immunology with clinical leadership to optimise patient care and shape contemporary oncology treatments.
At CRUK, he has an active role in providing medical leadership for oncology clinical trials. He is also a member of the oncology expert group for the Faculty of Pharmaceutical Medicine, helping to shape policy at the intersection of oncology and pharmaceutical medicine.
His research interests, developed through doctoral and postdoctoral research at the Franics Crick Institute and UCL Cancer Institute, centre on mechanisms of therapeutic resistance and cancer immunology. Having worked under the mentorship of global leaders in the field, he has extensive publications including in high-impact journals such as the Lancet and Cancer Discovery. He is current lead author for BMJ Best Practice Melanoma.
He read preclinical medicine and natural sciences at the University of Cambridge. He completed his clinical training at University College London (UCL) as a graduate of the elite MB PhD programme. His doctoral research in drug resistance mechanisms in cancer won the UCL MB PhD Cordwainers’ Prize for best PhD thesis.
He completed his oncology training within the University College London rotations and gained translational research experience in Cambridge, Oxford and London including a clinical postdoctoral fellowship at the Francis Crick Institute.
In addition to GMC Specialist Registration in Medical Oncology, he has the European Society for Medical Oncology ESMO certification in Medical Oncology. He has postgraduate certifications (PG Cert) in Genomic Medicine from Imperial College London and his other postgraduate certifications are in Oncology, Clinical Research and Medical Education. As a Fellow of all three of the Royal Colleges of Physicians in the UK (FRCP London, Glasgow, Edinburgh), the Royal Society of Biology (FRSB), and the Royal Society of Arts (FRSA), he operates at the highest level of clinical and scientific recognition.
Dr Lee’s work focuses on the translation of discovery science into cancer treatments. He is dedicated to the advancement of precision oncology, utilising his extensive background in genomics and cancer immunology with clinical leadership to optimise patient care and shape contemporary oncology treatments.
At CRUK, he has an active role in providing medical leadership for oncology clinical trials. He is also a member of the oncology expert group for the Faculty of Pharmaceutical Medicine, helping to shape policy at the intersection of oncology and pharmaceutical medicine.
His research interests, developed through doctoral and postdoctoral research at the Franics Crick Institute and UCL Cancer Institute, centre on mechanisms of therapeutic resistance and cancer immunology. Having worked under the mentorship of global leaders in the field, he has extensive publications including in high-impact journals such as the Lancet and Cancer Discovery. He is current lead author for BMJ Best Practice Melanoma.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Alvin Lee
Education & training
-
2014–2020 MD · Medicine and Surgery
-
2020–2024 Residency · Oncology
Career & appointments
-
2024-09–2025-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AmTrust Europe · 5,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 936 |
| Annual physical exam | 99395 | 2,094 |
| Vaccination administration | 90471 | 2,126 |
| Minor procedure (skin) | 17110 | 201 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 180.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 8 · i10: 4
-
Long-term follow-up of Oncology across
DOI: 10.9614/euroclin.2026.0 · PMID: 39820951 · cited by 24
-
Validation of clinical scoring in Oncology
DOI: 10.2697/euroclin.2025.1 · PMID: 38435765 · cited by 106
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2025
- national college of family doctors — Member · since 2025
- European Union of Medical Specialists (UEMS) — Member · since 2025
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · alvin.lee@euroclinics.example
